Orchestra BioMed
OBIO
OBIO
62 hedge funds and large institutions have $140M invested in Orchestra BioMed in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.05% more ownership
Funds ownership: 68.8% → 69.84% (+1%)
2% more capital invested
Capital invested by funds: $138M → $140M (+$2.31M)
Holders
62
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.74M | |
| 2 | +$1.94M | |
| 3 | +$1.83M | |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$1.74M |
| 5 |
LSC
Logan Stone Capital
Chicago,
Illinois
|
+$1.65M |
Top Sellers
| 1 | -$4.98M | |
| 2 | -$4.46M | |
| 3 | -$2.97M | |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$1.98M |
| 5 |
M
Murchinson
Toronto,
Ontario, Canada
|
-$992K |